Clinical studies with marihuana and tetrahydrocannabinols currently being allowed by the Food and Drug Administration

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|12|6|1019-1020

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.12, Iss.6, 1971-11, pp. : 1019-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pain palliation measurement in cancer clinical trials: The US Food and Drug Administration perspective

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 761-767

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 10, 2014-10 ,pp. : 720-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Under‐representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993‐2013

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 3025-3032

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 30-37

John Wiley & Sons Inc

Access to resources Recommend Favorite

"I am allowed to be myself": women with chronic muscular pain being recognized

By Steihaug Sissel   Ahlsen Birgitte   Malterud Kirsti  

Scandinavian Journal of Public Health, Vol. 30, Iss. 4, 2002-11 ,pp. : 281-287

Informa Healthcare

Access to resources Recommend Favorite